DNTH EBITDA Margin

Dianthus Therapeutics Inc · EBITDA Margin

DNTH logo

DNTH EBITDA Margin

Latest reported-1550.95%
DNTH TTM EBITDA Margin (-5383.21% → -1550.95%)
High-resolution chart · PNG

DNTH ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Dianthus Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-1,550.9454%
-819.7605%
21.0216%
-4,091.488%
-2,355.3358%
-1,537.3084%
-1,356.1668%
-1,242.1729%
-1,368.1642%
-1,607.2891%
-1,598.9384%
-1,263.9108%
-965.5154%
-1,406.6218%
-2,319.2078%
-5,383.2055%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.